1. Bachelor’s degree (180 credits) or equivalent with a major in chemistry, biochemistry, biomedical technology, biomedical methods and technology, biomedical laboratory science, or in other areas of natural, medical, engineering sciences or technology of relevance to the programme with a minimum of 15 credits in chemistry and/or biochemistry.

2. The equivalent of English B, or English 6, in Swedish secondary school.

The course aims to enable the students to identify artificial and biological interfaces relevant to Biomedical Surface Science.

Biomedical surface science is discussed defining the concept of artificial and biological interfaces. The role of artificial and biological interfaces in research and development of biomedical and biotech industries is emphasised. The main molecular, surface chemical and biological phenomena at artificial and biological interfaces are discussed with focus on their applications in biomedical methods and products of biomedical technology. The development and growth of biomedical and biotech industries worldwide and at the Malmö-Copenhagen (Öresund) region are analysed.

Upon completion of the course the student should be able to

1. explain biomedical surface science in terms of artificial and biological interfaces,

2. explain the main interactions at artificial and biological interfaces, and

3. explain how processes at artificial and biological interfaces are involved and used in the products or activities of biomedical and biotech industries.

Learning forms based on principles of the proper combination of passive (lectures) and active (seminars, discussions, labs and individual works) learning. For active learning (seminars, discussion, and individual work) independent literature studies, presentations, critical thinking, and problem solving, prevails. Different forms of reporting are used, namely written and oral for weekly seminars and labs reports.

The learning outcomes are examined through: completed laboratory experiments and approved reports, both oral and written, reports on individual works, presentations at seminars, and a written exam.

A student who fails to achieve a passing grade in the course examination will be given the opportunity to be re-examined twice according to same course content and with the same requirements. In addition, students also have the right to be examined on the same course the next time the course is offered according to the same regulations. If the course has been discontinued or undergone major changes, the student has a right to re-examination on two occasions within one year, based on the syllabus that was in place at the time the student registered for the course. Examination and re-examination take place at the times specified in the schedule.

Shreefal S, Mehta, (2008) Commercializing successful biomedical technologies. Basic principles for the development of drugs, diagnostics and devices. Cambridge University Press, Cambridge, pp. 335.

Medicon Valley Alliance. Directory (2008) Academia, Businesses and Public Organisations in Medicon Valley. Birch & co. a/s, Copenhagen, pp. 84.

To cover the contents of the course appropriate scientific papers will be distributed.

The course coordinator/examiner is responsible for ensuring that two course evaluations will be conducted for the course. A preliminary course evaluation will be conducted upon the completion of half of the course. The results will be compiled and relayed to the students as soon as possible. The results will be presented on the course website and will be relayed to students during lesson time. A summary course evaluation will be conducted in connection with the completion of the course. The course coordinator will relay the results to the students at a prearranged time. Memory notes from the feedback, including proposals for changes to the course, will be documented and made available on the course website, and will also be relayed to the students who begin the course the next time it is given.